Table 5-.

Clinical characteristics of HIV positive patients by duration of anti-retroviral therapy (ART) at breast cancer diagnosis

	Less than or equal to 1 year (n=30) **	More than 1 year (n=130) **	P-value*
Stage at BC diagnosis
Early Stage	13 (43.3%)	52 (40.3%)	0.76
Late Stage	17 (56.7%)	77 (59.7%)
Metastatic disease
No metastasis	23 (76.7%)	114 (87.7%)	0.12
Metastasis	7 (23.3%)	16 (12.3%)
IHC4 subtypes at diagnosis
Luminal A	5 (17.2%)	13 (10.7%)	0.19‡
Luminal B	21 (72.4%)	73 (60.3%)
Her2-positive	1 (3.5%)	8 (6.6%)
Triple Negative	2 (6.9%)	27 (22.3%)
Luminal B (ER+/PR+; Her2-; Ki67≥14%)	15 (71.4%)	42 (57.5%)	0.25
Luminal B (ER+/PR+; Her2+)	6 (28.6%)	31 (42.5%)

^*Chi square test,

^‡Fisher’s exact test and

^#Mann Whitney test comparing duration of ART.

^**Duration of ART missing for 66 HIV positive patients (29.2%).